InvestorsHub Logo
Followers 41
Posts 12405
Boards Moderated 0
Alias Born 11/18/2016

Re: gold007_2000 post# 87583

Thursday, 12/13/2018 5:58:41 PM

Thursday, December 13, 2018 5:58:41 PM

Post# of 108192
There is no way Amgen could have enough NEO data this soon to make them drop out after only a few patients. It wouldn’t cost them much to wait for more data. No milestones, apparently, are payable within this phase of the trial. Has to be a more strategic reason.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News